Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | 123I-ATT001 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on 123I-ATT001, a putative PARP inhibitor linked to the radioisotope I 123 (Oct 2024). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| 123I-ATT001 | 123I ATT001|123IATT001 | PARP Inhibitor (Pan) 29 | Limited information is currently available on 123I-ATT001, a putative PARP inhibitor linked to the radioisotope I 123 (Oct 2024). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06650605 | Phase I | 123I-ATT001 | Phase 1 Open-label Study of 123I-ATT001 in Subjects with Relapsed Glioblastoma (CITADEL-123) | Recruiting | GBR | 0 |